中國先鋒醫藥(01345.HK)擬更名爲"上海先鋒控股有限公司"
格隆匯9月8日丨中國先鋒醫藥(01345.HK)公告,董事會建議將公司英文名稱由"China Pioneer Pharma Holdings Limited"更改爲"Shanghai Pioneer Holding Ltd",並將公司中文雙重外國名稱由"中國先鋒醫藥控股有限公司"更改爲"上海先鋒控股有限公司"。
建議更改公司名稱須經(i)股東於股東特別大會上通過特別決議案批準建議更改公司名稱;及(ii)開曼羣島公司註冊處處長髮出更改名稱註冊證書批準建議更改公司名稱後,方告作實。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.